Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging

Investigative Radiology

Volumn 32, Issue 12, 1997, Pages 741-747

  Parmelee, David J ^a   Walovitch, Richard C ^a   Ouellet, Hillori S ^a   Lauffer, Randall B ^a  

^a EPIX Medical Inc   (United States)

Author keywords

Contrast media; Gadolinium; Magnetic resonance angiography; Pharmacokinetics

Indexed keywords

CONTRAST MEDIUM; GADOFOSVESET; GADOLINIUM 153; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BILIARY EXCRETION; BLOOD; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONKEY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; RAT;

EID: 0031435887     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199712000-00004     Document Type: Article

References (18)

1. Lauffer RB, Parmelee DJ, Quellet HS, et al. MS-325: A small molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996;S356-S358.
2. Dunham SU, Witte S. Parmelee DJ, Lauffer RB. Comparative study of signal enhancement capabilities of three classes of contrast agents for MRA. Proc Int Soc Mag Res Med 1997;1864.
3. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: An albumin-targeted contrast agent for MR angiography. Submitted for publication.
4. Grist TM, Korosec FR, Peters DC, Walovitch RC, Yucel EK, Misretta C. Steady state and dynamic MR angiographic imaging with MS-325: initial experience in humans. Proc Int Soc Mag Res Med 1997;207.
5. Grist TM, Korosec FR, Peters DC, et al. Steady state and dynamic MR angiographic imaging with MS-325: initial experience in humans. Submitted for publication.
6. Rowland M, Tozer TN. Small volume of distribution. In: Balado D, ed. Clinical pharmacokinetics: concepts and applications. Baltimore: Lea & Feibiger, 1995:149-152.
7. Ritschel WA. Handbook of basic pharmacokinetics. Hamilton, IL: Drug Intelligence Publications, 1992:588.
8. Harpur ES, Worah D, Hals P-A, Holtz E, Furuhama K, Nomura H. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 1993;28:S28-S43.
9. Schmeidl U, Ogan M, Moseley M, Brasch R. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: An experimental study in rats. AJR Am J Roentgenol 1986;147:126-1270.
10. Wang SC, Wikstrom MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology 1990; 175:483-488.
11. Meyer D, Schaefer M, Bouillot A, Beaute S, Chambon C. Paramagnetic dextrans as magnetic resonance contrast agents. Invest Radiol 1991;26:S50-S52; discussion S60-S64.
12. Li KC, Quisling RG, Armitage FE, Richardson D, Mladinich C. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits. Magn Reson Imaging 1992;10:439-444.
13. Bogdanov AA Jr, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies. Radiology 1993;187:701-706.
14. Adam G, Neuerburg J, Spuntrup E, Mühler A, Scherer K, Gunther RW. Dynamic contrast-enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994;32:622-628.
15. Desser T, Rubin D, Fan Q, et al. Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agents. Invest Radiol 1994;29:S65-S68.
16. Brodersen R, Honore B, Larsen FG. Serum albumin-a non-saturable carrier. Acta Pharmacologica et Toxicologica 1984;54:129-133.
17. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-215.
18. Schuhmann-Giampieri G. Liver contrast media for magnetic resonance imaging: Interrelations between pharmacokinetics and imaging. Invest Radiol 1993;28:753-761.